Troy Loge

Troy Loge serves as the primary contracting lead for the W40M MRC0 West agency under the Department of the Army, responsible for managing complex acquisitions that sustain military medical readiness. He oversees the procurement of critical in-vitro diagnostic substances, surgical instruments, sterilization systems, and blood management technologies essential for field-deployable, high-acuity care. His role is central to ensuring operational sovereignty by securing mission-critical medical capabilities that support combat casualty care and laboratory diagnostics in austere environments. Loge handles a diverse portfolio of contract types, including indefinite-delivery/indefinite-quantity (IDIQ) and requirements contracts, with a strong emphasis on technical compliance and supply chain resilience. Loge maintains consistent working relationships with leading medical technology providers, including Roche Diagnostics Corporation, Cardinal Health 414, LLC, and Surgical Neuromonitoring Associates, Inc. These partnerships reflect a focus on high-reliability vendors capable of delivering FDA-regulated, military-specification medical products under strict logistics and quality control standards. He frequently engages with specialized contractors such as KJ Trauma Consulting LLC for niche operational support services, indicating a preference for vendors with proven field experience in military medical environments. His contracting patterns prioritize established suppliers with demonstrated capacity for rapid deployment and regulatory adherence. While the majority of his acquisitions are unrestricted—82.9% of awards are issued without set-asides—Loge maintains a deliberate 17.1% commitment to total small business set-asides under FAR 19.5. This reflects a balanced approach: leveraging large-scale vendor capabilities while actively integrating qualified small businesses into the medical supply chain. His socioeconomic contracting strategy prioritizes broad-based small business participation over narrow socio-economic categories, aligning with the agency’s need for scalable, reliable sourcing. Loge’s procurement focus centers on NAICS 622110 (General Medical and Surgical Hospitals), 325412 (Pharmaceutical Preparation Manufacturing), and 325413 (In-Vitro Diagnostic Substance Manufacturing), underscoring deep expertise in diagnostic reagents, sterile surgical kits, and automated lab systems. He regularly procures Class II and III medical devices, blood storage and transfusion equipment, and sterilization validation systems, demonstrating specialized knowledge in FDA and DoD regulatory frameworks governing medical technology acquisition.